lobbying_activities: 1108565

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1108565	2a42bac7-5cbb-410d-b7cc-8290d7153cf3	Q2	BUCHANAN INGERSOLL & ROONEY PC	55291	SHIRE PHARMACEUTICALS INC	2011	second_quarter	PHA	Life Sciences Investment Act; ESRD bundling, ESRD Quality Incentive program; orphan drugs; health care reform implementation; DEA Quotas; Drug shortage; CMS issues	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2011-07-08T13:19:56.510000-04:00